QXL138AM
A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma
Arms / Cohorts
Experimental, Phase 1a Dose Escalation:Part A1: QXL138AM Dose Escalation in Solid Tumors
Accepting patients
Experimental, Phase 1a Dose Escalation:Part A2: QXL138AM Dose Escalation in Multiple Myeloma
Accepting patients
Experimental, Phase 1b Dose Escalation:Part B1: QXL138AM Dose Expansion in Solid Tumors
Not yet accepting
Experimental, Phase 1b Dose Escalation:Part B2: QXL138AM Dose Expansion in Multiple Myeloma
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.